Annual Accounts Receivable
$9.76 M
-$3.41 M-25.87%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual accounts receivable is $9.76 million, with the most recent change of -$3.41 million (-25.87%) on December 31, 2023.
- During the last 3 years, CPIX annual accounts receivable has fallen by -$2.62 million (-21.16%).
- CPIX annual accounts receivable is now -25.87% below its all-time high of $13.16 million, reached on December 31, 2022.
Performance
CPIX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$11.31 M
-$309.20 K-2.66%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly accounts receivable is $11.31 million, with the most recent change of -$309.20 thousand (-2.66%) on September 30, 2024.
- Over the past year, CPIX quarterly accounts receivable has increased by +$1.55 million (+15.91%).
- CPIX quarterly accounts receivable is now -25.75% below its all-time high of $15.23 million, reached on September 30, 2022.
Performance
CPIX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CPIX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.9% | +15.9% |
| 3 y3 years | -21.2% | +14.8% |
| 5 y5 years | +24.4% | +43.9% |
CPIX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.9% | +41.9% | -25.8% | +64.5% |
| 5 y | 5-year | -25.9% | +41.9% | -25.8% | +90.1% |
| alltime | all time | -25.9% | +311.1% | -25.8% | +427.9% |
Cumberland Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.31 M(-2.7%) |
| Jun 2024 | - | $11.62 M(+9.1%) |
| Mar 2024 | - | $10.65 M(+9.1%) |
| Dec 2023 | $9.76 M(-25.9%) | $9.76 M(-22.7%) |
| Sep 2023 | - | $12.62 M(+3.3%) |
| Jun 2023 | - | $12.22 M(-15.9%) |
| Mar 2023 | - | $14.53 M(+10.4%) |
| Dec 2022 | $13.16 M(+91.4%) | $13.16 M(-13.6%) |
| Sep 2022 | - | $15.23 M(+14.7%) |
| Jun 2022 | - | $13.28 M(-9.3%) |
| Mar 2022 | - | $14.64 M(+112.8%) |
| Dec 2021 | $6.88 M(-44.4%) | $6.88 M(-30.2%) |
| Sep 2021 | - | $9.85 M(+7.7%) |
| Jun 2021 | - | $9.15 M(-27.1%) |
| Mar 2021 | - | $12.55 M(+1.4%) |
| Dec 2020 | $12.38 M(+57.5%) | $12.38 M(+28.1%) |
| Sep 2020 | - | $9.66 M(+21.9%) |
| Jun 2020 | - | $7.92 M(+33.2%) |
| Mar 2020 | - | $5.95 M(-24.3%) |
| Dec 2019 | $7.86 M(+0.2%) | $7.86 M(-5.3%) |
| Sep 2019 | - | $8.30 M(-1.5%) |
| Jun 2019 | - | $8.43 M(-15.5%) |
| Mar 2019 | - | $9.97 M(+27.2%) |
| Dec 2018 | $7.84 M(-6.6%) | $7.84 M(+11.2%) |
| Sep 2018 | - | $7.06 M(+21.5%) |
| Jun 2018 | - | $5.81 M(-7.9%) |
| Mar 2018 | - | $6.30 M(-24.9%) |
| Dec 2017 | $8.40 M(+14.5%) | $8.40 M(+16.5%) |
| Sep 2017 | - | $7.21 M(+18.0%) |
| Jun 2017 | - | $6.11 M(+23.8%) |
| Mar 2017 | - | $4.93 M(-32.7%) |
| Dec 2016 | $7.33 M(+20.6%) | $7.33 M(+9.9%) |
| Sep 2016 | - | $6.67 M(+46.6%) |
| Jun 2016 | - | $4.55 M(-5.6%) |
| Mar 2016 | - | $4.82 M(-20.6%) |
| Dec 2015 | $6.08 M | $6.08 M(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $5.80 M(-0.2%) |
| Jun 2015 | - | $5.81 M(+12.2%) |
| Mar 2015 | - | $5.17 M(-6.0%) |
| Dec 2014 | $5.50 M(+21.5%) | $5.50 M(+3.9%) |
| Sep 2014 | - | $5.30 M(-11.9%) |
| Jun 2014 | - | $6.01 M(+11.0%) |
| Mar 2014 | - | $5.42 M(+19.6%) |
| Dec 2013 | $4.53 M(-24.7%) | $4.53 M(+8.0%) |
| Sep 2013 | - | $4.19 M(+5.6%) |
| Jun 2013 | - | $3.97 M(-33.5%) |
| Mar 2013 | - | $5.97 M(-0.8%) |
| Dec 2012 | $6.02 M(-15.0%) | $6.02 M(+10.1%) |
| Sep 2012 | - | $5.47 M(+9.5%) |
| Jun 2012 | - | $4.99 M(+11.8%) |
| Mar 2012 | - | $4.46 M(-37.0%) |
| Dec 2011 | $7.08 M(+37.7%) | $7.08 M(+57.2%) |
| Sep 2011 | - | $4.51 M(-6.5%) |
| Jun 2011 | - | $4.82 M(-6.3%) |
| Mar 2011 | - | $5.15 M(+0.0%) |
| Dec 2010 | $5.15 M(-16.7%) | $5.15 M(+7.4%) |
| Sep 2010 | - | $4.79 M(+21.0%) |
| Jun 2010 | - | $3.96 M(+3.8%) |
| Mar 2010 | - | $3.81 M(-38.2%) |
| Dec 2009 | $6.18 M(+97.4%) | $6.18 M(-15.2%) |
| Sep 2009 | - | $7.28 M(+123.8%) |
| Jun 2009 | - | $3.25 M(-4.2%) |
| Mar 2009 | - | $3.40 M(+8.6%) |
| Dec 2008 | $3.13 M(+31.8%) | $3.13 M(-2.3%) |
| Sep 2008 | - | $3.20 M(+6.7%) |
| Jun 2008 | - | $3.00 M(+2.9%) |
| Mar 2008 | - | $2.92 M(+22.9%) |
| Dec 2007 | $2.37 M(-53.6%) | $2.37 M(-15.9%) |
| Sep 2007 | - | $2.82 M(+16.9%) |
| Jun 2007 | - | $2.41 M(+12.6%) |
| Mar 2007 | - | $2.14 M(-58.2%) |
| Dec 2006 | $5.12 M(+112.0%) | $5.12 M |
| Dec 2005 | $2.41 M | - |
FAQ
- What is Cumberland Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual accounts receivable year-on-year change?
- What is Cumberland Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Cumberland Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of CPIX is $9.76 M
What is the all time high annual accounts receivable for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual accounts receivable is $13.16 M
What is Cumberland Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, CPIX annual accounts receivable has changed by -$3.41 M (-25.87%)
What is Cumberland Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of CPIX is $11.31 M
What is the all time high quarterly accounts receivable for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly accounts receivable is $15.23 M
What is Cumberland Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, CPIX quarterly accounts receivable has changed by +$1.55 M (+15.91%)